DC-CIK细胞联合内分泌治疗骨髓侵润性前列腺癌初探  

The preliminary study on prostate cancer with bone marrow contamination by endocrine therapy combined with dendritic cells and cytokine-induced killer cells

作　　者：范方毅[1] 王译[1] 苏毅[1] 邱玲[1] 刘一岚 胡晓莉[1] 易海[1] 付利[1] 

机构地区：[1]成都军区总医院血液内科,四川成都610083

出　　处：《西部医学》2013年第2期238-239,241,共3页Medical Journal of West China

摘　　要：目的探讨DC-CIK细胞联合内分泌治疗骨髓侵润性前列腺癌的疗效及副作用。方法对3例骨髓侵润的前列腺癌患者采用DC-CIK细胞输注联合内分泌治疗。结果 3例患者经治疗后临床症状好转,PSA下降,随访8～13个月,病情稳定。结论 DC-CIK细胞联合内分泌治疗骨髓侵润的前列腺癌安全有效。Objective To observe the safety and efficacy of endocrine therapy combined with dendritic cells and cytokine-induced killer cells on prostate cancer with bone marrow contamination. Methods three patients receive the treatment of endocrine therapy combined with dendritic cells and cytokine-induced killer cells. Results After the treatment, the PSA of three patients decreased, the clinical symptoms improved. During follow-up, the disease continued to show a steady state. Conclusion The treatment of endocrine therapy combined with dendritic cells and cytokine-induced killer cells is effective and safe.

关 键 词：前列腺癌 内分泌治疗 DC-CIK细胞 

分 类 号：R737.25[医药卫生—肿瘤]